Michele G. Sullivan
Fluoroquinolones can cause fatal hypoglycemia, FDA warns
July 11, 2018
The FDA is strengthening warning labels on fluoroquinolones to reflect the risk of life-threatening hypoglycemia and neuropsychiatric adverse events.
New look at ATLAS suggests rivaroxaban may still have role in ACS
July 2, 2018
A reanalysis of the ATLAS ACS 2-TIMI 51 trial separated fatal and nonfatal events.
Medicare hospital deaths decline, hospice usage increases
June 26, 2018
During 2000-2015, Medicare recipients became less likely to die in hospitals.
Buprenorphine endangers lives and health of children
June 25, 2018
Although important for treatment of opioid exposure, buprenorphine exposure can result in serious adverse effects in children who ingest it.
Hospital-acquired conditions drop 8% since 2014, saving 8,000 lives and $3 billion
June 8, 2018
The largest improvements occurred in central line–associated bloodstream infections (down 31% from 2014).
MDR Candida auris is on the move
May 24, 2018
MADRID - C. auris made its first appearance in Spain 2 years ago, and infection control specialists are still struggling to eradicate it.
For Gram-negative bacteremias, 7 days of antibiotics is enough
May 20, 2018
MADRID – Two weeks of antibiotic treatment conferred no benefits over 7 days of treatment in patients with Gram-negative bacteremias.
Three days of beta-lactam beat clinically stable CAP
May 19, 2018
For some community-acquired pneumonia patients, short-term antibiotic therapy is a viable alternative to traditional longer courses.
ESBL-B before colorectal surgery ups risk of surgical site infection
May 17, 2018
MADRID – ESBL-B appears to be a factor in infection after colorectal surgery.
ESBL-resistant bacteria spread in hospital despite strict contact precautions
May 14, 2018
Adherence to strict contact isolation and hand hygiene is never 100% in a real-life scenario.